KPF
DMIIR icon

K2 Principal Fund’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

K2 Principal Fund’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20K Hold
250,000
– – ﹤0.01% 449
2026
Q1 		$20K Hold
250,000
– – ﹤0.01% 447
2025
Q4 		$35K Buy
+250,000
New +$35.7K ﹤0.01% 371

Other funds holding DMIIR

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HGC Investment Management
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

K2 Principal Fund's DMIIR Position: Q2 2026 in Review

K2 Principal Fund held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q2 2026 at 250,000 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

K2 Principal Fund first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. The position peaked at $35K in Q4 2025. 62 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • K2 Principal Fund held 250,000 shares of Drugs Made In America Acquisition II Corp Right worth $20K as of Q2 2026.
  • K2 Principal Fund left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of K2 Principal Fund's portfolio in Q2 2026, its #449 holding.
  • K2 Principal Fund first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
  • K2 Principal Fund's Drugs Made In America Acquisition II Corp Right position peaked at $35K in Q4 2025.
  • 62 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on K2 Principal Fund's 13F filing for Q2 2026, filed 7 Aug 2026.